EY to acquire life science tech firm Aqurance
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
India currently hosts more than 10,075 biotech startups
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
CRISPR-based detection enables highly specific molecular recognition
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Subscribe To Our Newsletter & Stay Updated